Browsing by Author van Zandwijk, Nico

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 47  next >
Issue DateTitleAuthor(s)Citation
2017The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detectionReid, Glen; van Zandwijk, Nico; Williams, Marissa; Winata, Patrick; McGowan, Eileen; Nassif, Najah; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Medicine; Concord Clinical School: MedicineThe analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detection, BMC Research Notes, vol.10, 1, 2017,pp 1-7
2013Cell-free microRNAs: potential biomarkers in need of standardized reportingKirschner, Michaela; Reid, Glen; van Zandwijk, Nico; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteCell-free microRNAs: potential biomarkers in need of standardized reporting, Frontiers in Genetics, vol.4, N/A, 2013,pp 1-5
2011Cetuximab in combination with single agent daily cisplatin chemotherapy concurrent with radiotherapy in locally advanced nonsmall cell lung carcinoma: A feasibility studyvan Zandwijk, Nico; Aukema, T; Belderbos, Jose; Schaake, E; Uyterlinde, W; Valdes Olmos, Renato A; Van den Heuvel, Michel M; Verheij, Marcel; Vincent, A; Concord Clinical School: ANZAC Research InstituteCetuximab in combination with single agent daily cisplatin chemotherapy concurrent with radiotherapy in locally advanced nonsmall cell lung carcinoma: A feasibility study, The European Journal of Clinical & Medical Oncology, vol.3, 3, 2011,pp 65-71
2014Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins αvβ3 and αvβ5Cheng, Ngan Ching; Reid, Glen; van Zandwijk, Nico; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteCilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins αvβ3 and αvβ5, PLoS One, vol.9, 3, 2014,pp 1-10
2016Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional studyKao, Steven; Reid, Glen; van Zandwijk, Nico; Dong, Yawen; et al, .; Ghanim, Bahil; Hoda, Mir Alireza; Jakopovic, Marko; Klikovits, Thomas; Laszlo, Viktoria; Ozsvar, Judit; Rozsas, Anita; Stockhammer, Paul; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteCirculating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study, European Journal of Cancer, vol.63, N/A, 2016,pp 64-73
2011Circulating microRNAs: Association with disease and potential use as biomarkersKirschner, Michaela; Reid, Glen; van Zandwijk, Nico; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteCirculating microRNAs: Association with disease and potential use as biomarkers, Critical Reviews in Oncology/Hematology, vol.80, 2, 2011,pp 193-208
2016Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancerBoyer, Michael; Clarke, Stephen; Kao, Steven; Pavlakis, Nick; Reid, Glen; van Zandwijk, Nico; Brahmbhatt, Himanshu; MacDiarmid, Jennifer; Central Clinical School: Medicine; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Northern Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteClinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer, Epigenomics, vol.8, 8, 2016,pp 1079-1085
2010Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Studyvan Zandwijk, Nico; Allan, S; Baliko, Zoltan; Gridelli, C; Heigener, David; Krzakowski, Maciej; Reck, Martin; Rischin, D.; Concord Clinical School: ANZAC Research InstituteErlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study, Journal of Thoracic Oncology, vol.5, 10,pp 1616-1622
2016Estimating the incidence of malignant mesothelioma in Vietnam: A pilot descriptive cancer registration studySoeberg, Matthew; van Zandwijk, Nico; Bui, Dieu Tien; Luong, Maianh; Nguyen, Thị Thu Huyen; Nguyen, Thi Hoai Nga; Takahashi, Ken; Tran, Anh Thanh; Van Tran, Thuan; School of Public Health: Public Health; Concord Clinical School: ANZAC Research InstituteEstimating the incidence of malignant mesothelioma in Vietnam: A pilot descriptive cancer registration study, International Journal of Occupational and Environmental Health, vol.22, 2, 2016,pp 167-172
2015Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer careClarke, Stephen; Kao, Steven; van Zandwijk, Nico; Vardy, Janette; Lumba, Sumit; Ng, Weng; Tognela, Annette; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineEstimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer care, Asia-Pacific Journal of Clinical Oncology, vol.11, N/A, 2015,pp 85-92
2017Estimation of the global burden of mesothelioma deaths from incomplete national mortality dataDriscoll, Timothy; Takahashi, Ken; van Zandwijk, Nico; Fitzmaurice, Christina; Furuya, Sugio; Horie, Seichi; Odgerel, Chimed-Ochir; Sawanyawisuth, Kittisak; Sorahan, Tom; Takala, Jukka; Tanaka, Fumihiro; Yoko-o, Makoto; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: MedicineEstimation of the global burden of mesothelioma deaths from incomplete national mortality data, Occupational and Environmental Medicine, vol.74, 12, 2017,pp 851-858
2013Excision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With MesotheliomaClarke, Stephen; Kao, Steven; van Zandwijk, Nico; Vardy, Janette; Henderson, Douglas; Klebe, Sonja; Lee, Kenneth; McCaughan, Brian; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineExcision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With Mesothelioma, Clinical Lung Cancer, vol.14, 2, 2013,pp 164-171
2014Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South WalesClarke, Stephen; Kao, Steven; Linton, Anthony; Pavlakis, Nick; Soeberg, Matthew; van Zandwijk, Nico; Vardy, Janette; O’Connell, R; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Northern Clinical School: Medicine; School of Public Health: Public Health; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineFactors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales, British Journal of Cancer, vol.111, 9, 2014,pp 1860-1869
2015Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosisEdelman, John (James); Kao, Steven; Kirschner, Michaela; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Cheng, YuenYee; Dong, Yawen; Emily, Pulford; et al, Various; Griggs, Kim; Grusch, Michael; Hoda, Mir Alireza; Hyland, Rebecca; Klikovits, Thomas; Laszlo, Viktoria; Rozsas, Anita; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteFibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis, British Journal of Cancer, vol.113, 6, 2015,pp 963-969
2017Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomesKao, Steven; Linton, Anthony; van Zandwijk, Nico; Broome, R; Soeberg, Matthew; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: MedicineGeographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes, Respirology, vol.22, 5, 2017,pp 978-985
2011Haemolysis during Sample Preparation Alters microRNA Content of Plasma.Edelman, John; Kao, Steven; Kirschner, Michaela; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Armstrong, Nicola; School of Medical Sciences: Physiology; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteHaemolysis during Sample Preparation Alters microRNA Content of Plasma., PLoS One, vol.6, 9, 2011,pp e24145-N/A
2010High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapyBoyer, Michael; Clarke, Stephen; Pavlakis, Nick; van Zandwijk, Nico; Vardy, Janette; Harvie, Rozelle; Kao, S. C. H.; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Northern Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineHigh blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy, Clinical Cancer Research, vol.16, 23,pp 5805-5813
2013Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature reviewClarke, Stephen; Kao, Steven; Linton, Anthony; van Zandwijk, Nico; Vardy, Janette; Klebe, Sonja; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineImmunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature review, Asia Pacific Journal of Clinical Oncology, vol.9, 3, 2013,pp 273-279
2013The Impact of Hemolysis on Cell-Free microRNA BiomarkersEdelman, John (James); Kao, Steven; Kirschner, Michaela; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteThe Impact of Hemolysis on Cell-Free microRNA Biomarkers, Frontiers in Genetics, vol.4, N/A, 2013,pp 1-13
2016Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009Armstrong, Bruce; Driscoll, Timothy; Leigh, James; Soeberg, Matthew; van Zandwijk, Nico; Young, Jane; School of Public Health: Public Health; School of Public Health: Public Health; School of Public Health: Public Health; School of Public Health: Public Health; Concord Clinical School: ANZAC Research Institute; School of Public Health: Public HealthIncidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009, Occupational and Environmental Medicine, vol.73, 3, 2016,pp 187-194